1.
Murer C, Huber LC, Kurowski T, Hirt A, Robinson C, Bürgi U, Benden C. First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial – preliminary results. Swiss Med Wkly [Internet]. 2018 Feb. 16 [cited 2024 Nov. 24];148(0708):w14593. Available from: https://smw.ch/index.php/smw/article/view/2449